Boston Scientific (BSX) Other Non-Current Assets (2009 - 2026)
Boston Scientific's (BSX) quarterly Other Non-Current Assets came in at $45.2 billion in Q2 2026, up 8.8% year-over-year from $41.6 billion in Q2 2025, and up 1.95% quarter-over-quarter from $44.4 billion in Q1 2026.
Analysis
Boston Scientific (BSX) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Boston Scientific has disclosed Other Non-Current Assets across 18 years of filings, most recently posting $45.2 billion for Q2 2026.
- In Q2 2026, Other Non-Current Assets rose 8.8% year-over-year to $45.2 billion; the TTM figure through Jun 2026 stood at $45.2 billion (up 8.8% YoY), while the FY2025 annual figure was $43.7 billion, up 10.86% from the prior year.
- Other Non-Current Assets came in at $45.2 billion for Q2 2026 at Boston Scientific, up from $44.4 billion in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $45.2 billion in Q2 2026 to a low of $1.4 billion in Q1 2022.
- Average Other Non-Current Assets over 5 years is $21.0 billion, with a median of $17.1 billion recorded in 2022.
- Year-over-year, Other Non-Current Assets fell 19.78% in 2022 and soared 2579.5% in 2025.
- Over 5 years, Other Non-Current Assets stood at $32.5 billion in 2022, then rose by 8.21% to $35.1 billion in 2023, then climbed by 12.12% to $39.4 billion in 2024, then climbed by 10.86% to $43.7 billion in 2025, then gained by 3.53% to $45.2 billion in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $45.2 billion in Q2 2026, $44.4 billion in Q1 2026, and $43.7 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 4.32 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 3.23 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 616.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 434.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 273.70 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 1.08 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.22 Bn |
| Mar 31, 2026 | 44.35 Bn |
| Dec 31, 2025 | 43.67 Bn |
| Sep 30, 2025 | 42.71 Bn |
| Jun 30, 2025 | 41.56 Bn |
| Mar 31, 2025 | 40.14 Bn |
| Dec 31, 2024 | 39.40 Bn |
| Sep 30, 2024 | 1.64 Bn |
| Jun 30, 2024 | 1.55 Bn |
| Mar 31, 2024 | 1.60 Bn |
| Dec 31, 2023 | 35.14 Bn |
| Sep 30, 2023 | 1.61 Bn |
| Jun 30, 2023 | 1.60 Bn |
| Mar 31, 2023 | 1.48 Bn |
| Dec 31, 2022 | 32.47 Bn |
| Sep 30, 2022 | 1.60 Bn |
| Jun 30, 2022 | 1.57 Bn |
| Mar 31, 2022 | 1.38 Bn |
| Dec 31, 2021 | 1.41 Bn |
| Sep 30, 2021 | 1.44 Bn |